132 related articles for article (PubMed ID: 16103047)
1. The neurotrophic receptor TrkB in anoikis resistance and metastasis: a perspective.
Geiger TR; Peeper DS
Cancer Res; 2005 Aug; 65(16):7033-6. PubMed ID: 16103047
[TBL] [Abstract][Full Text] [Related]
2. Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB.
Douma S; Van Laar T; Zevenhoven J; Meuwissen R; Van Garderen E; Peeper DS
Nature; 2004 Aug; 430(7003):1034-9. PubMed ID: 15329723
[TBL] [Abstract][Full Text] [Related]
3. Critical role for TrkB kinase function in anoikis suppression, tumorigenesis, and metastasis.
Geiger TR; Peeper DS
Cancer Res; 2007 Jul; 67(13):6221-9. PubMed ID: 17616679
[TBL] [Abstract][Full Text] [Related]
4. Neurotrophic receptor TrkB: Is it a predictor of poor prognosis for carcinoma patients?
Han L; Zhang Z; Qin W; Sun W
Med Hypotheses; 2007; 68(2):407-9. PubMed ID: 17008023
[TBL] [Abstract][Full Text] [Related]
5. Anoikis: cancer and the homeless cell.
Liotta LA; Kohn E
Nature; 2004 Aug; 430(7003):973-4. PubMed ID: 15329701
[No Abstract] [Full Text] [Related]
6. Dieldrin promotes resistance to anoikis in breast cancer cells in vitro.
Cameron HL; Foster WG
Reprod Toxicol; 2008 Feb; 25(2):256-62. PubMed ID: 18242054
[TBL] [Abstract][Full Text] [Related]
7. Implications of tropomyosin-related kinase B (TrkB) in head and neck cancer.
Zhu L; Werner JA; Mandic R
Anticancer Res; 2007; 27(5A):3121-6. PubMed ID: 17970052
[TBL] [Abstract][Full Text] [Related]
8. A Twist-Snail axis critical for TrkB-induced epithelial-mesenchymal transition-like transformation, anoikis resistance, and metastasis.
Smit MA; Geiger TR; Song JY; Gitelman I; Peeper DS
Mol Cell Biol; 2009 Jul; 29(13):3722-37. PubMed ID: 19414595
[TBL] [Abstract][Full Text] [Related]
9. Suppression of anoikis by the neurotrophic receptor TrkB in human ovarian cancer.
Yu X; Liu L; Cai B; He Y; Wan X
Cancer Sci; 2008 Mar; 99(3):543-52. PubMed ID: 18201274
[TBL] [Abstract][Full Text] [Related]
10. Critical role for Fas-associated death domain-like interleukin-1-converting enzyme-like inhibitory protein in anoikis resistance and distant tumor formation.
Mawji IA; Simpson CD; Hurren R; Gronda M; Williams MA; Filmus J; Jonkman J; Da Costa RS; Wilson BC; Thomas MP; Reed JC; Glinsky GV; Schimmer AD
J Natl Cancer Inst; 2007 May; 99(10):811-22. PubMed ID: 17505076
[TBL] [Abstract][Full Text] [Related]
11. Involvement of visinin-like protein-1 (VSNL-1) in regulating proliferative and invasive properties of neuroblastoma.
Xie Y; Chan H; Fan J; Chen Y; Young J; Li W; Miao X; Yuan Z; Wang H; Tam PK; Ren Y
Carcinogenesis; 2007 Oct; 28(10):2122-30. PubMed ID: 17615261
[TBL] [Abstract][Full Text] [Related]
12. Involvement of anoikis-resistance in the metastasis of hepatoma cells.
Cao L; Han L; Zhang Z; Li J; Qu Z; Du J; Liang X; Liu Y; Liu H; Shi Y; Liu S; Gao L; Sun W
Exp Cell Res; 2009 Apr; 315(7):1148-56. PubMed ID: 19073174
[TBL] [Abstract][Full Text] [Related]
13. Neurotrophic receptor, tropomyosin-related kinase B as an independent prognostic marker in gastric cancer patients.
Tanaka K; Mohri Y; Nishioka J; Kobayashi M; Ohi M; Miki C; Tonouchi H; Nobori T; Kusunoki M
J Surg Oncol; 2009 Apr; 99(5):307-10. PubMed ID: 19170129
[TBL] [Abstract][Full Text] [Related]
14. TrkB as a therapeutic target for ovarian cancer.
Siu MK; Wong OG; Cheung AN
Expert Opin Ther Targets; 2009 Oct; 13(10):1169-78. PubMed ID: 19694498
[TBL] [Abstract][Full Text] [Related]
15. CUB domain-containing protein 1 is a novel regulator of anoikis resistance in lung adenocarcinoma.
Uekita T; Jia L; Narisawa-Saito M; Yokota J; Kiyono T; Sakai R
Mol Cell Biol; 2007 Nov; 27(21):7649-60. PubMed ID: 17785447
[TBL] [Abstract][Full Text] [Related]
16. A chemical screen identifies anisomycin as an anoikis sensitizer that functions by decreasing FLIP protein synthesis.
Mawji IA; Simpson CD; Gronda M; Williams MA; Hurren R; Henderson CJ; Datti A; Wrana JL; Schimmer AD
Cancer Res; 2007 Sep; 67(17):8307-15. PubMed ID: 17804746
[TBL] [Abstract][Full Text] [Related]
17. Galectin-1 is a major effector of TrkB-mediated neuroblastoma aggressiveness.
Cimmino F; Schulte JH; Zollo M; Koster J; Versteeg R; Iolascon A; Eggert A; Schramm A
Oncogene; 2009 May; 28(19):2015-23. PubMed ID: 19363525
[TBL] [Abstract][Full Text] [Related]
18. [Blocking TrkB-BDNF signal pathway decreases the livability of neuroblastoma cells].
Zhang JH; Li AM; Chen S; Tong HX; Zhang KR; Zhang JH
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb; 10(1):47-50. PubMed ID: 18289471
[TBL] [Abstract][Full Text] [Related]
19. Functional characterization of human cancer-derived TRKB mutations.
Geiger TR; Song JY; Rosado A; Peeper DS
PLoS One; 2011 Feb; 6(2):e16871. PubMed ID: 21379385
[TBL] [Abstract][Full Text] [Related]
20. DR5 receptor mediates anoikis in human colorectal carcinoma cell lines.
Laguinge LM; Samara RN; Wang W; El-Deiry WS; Corner G; Augenlicht L; Mishra L; Jessup JM
Cancer Res; 2008 Feb; 68(3):909-17. PubMed ID: 18245494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
